GLP-1 vs Other Weight Loss Drugs: A Complete Comparison
With so many weight loss medications available, choosing the right one can be overwhelming. Here's how GLP-1 receptor agonists like semaglutide compare to other popular weight loss treatments.
GLP-1 Agonists vs Phentermine
Phentermine is an older appetite suppressant that works by stimulating the central nervous system. While effective short-term (3-6 months), it carries risks of dependency and cardiovascular side effects. GLP-1 agonists like semaglutide provide superior weight loss (15-20% vs 5-10%) with a better safety profile and can be used long-term.
GLP-1 Agonists vs Orlistat (Alli/Xenical)
Orlistat blocks fat absorption in the gut, producing modest weight loss of 5-7% body weight. GLP-1 agonists work through appetite reduction and metabolic improvement, achieving 2-3x greater weight loss with fewer gastrointestinal side effects.
Semaglutide vs Tirzepatide
Tirzepatide (Mounjaro/Zepbound) is a newer dual GIP/GLP-1 agonist showing up to 22% weight loss in trials. Semaglutide achieves 15-20%. Both are excellent options. Read our detailed semaglutide vs tirzepatide comparison.
GLP-1 Agonists vs Bariatric Surgery
Bariatric surgery remains the most effective weight loss intervention (25-35% weight loss) but involves surgical risks, recovery time, and permanent anatomical changes. GLP-1 medications offer a non-surgical alternative with significant results. Many patients try GLP-1 therapy first.
Why GLP-1 Receptor Agonists Are Leading the Field
GLP-1 receptor agonists have become the preferred weight loss medication because they combine strong efficacy with manageable side effects, once-weekly dosing convenience, and additional health benefits including cardiovascular protection and improved blood sugar control. Explore the full benefits of GLP-1 therapy.